Last spring, Eli Lilly reported its drugs Humalog and insulin lispro were ... them that patients with Type 1 diabetes need short-acting insulin. "We are concerned that continued supply disruptions ...

Insulin lispro, the rapid-acting component of Humalog Mix75/25, has been shown to be equipotent to Regular human insulin on a molar basis. Instruct patients on diet, exercise, blood or urine ...

The primary activity of insulin including Humalog Mix50/50 is the regulation of glucose metabolism. Insulins lower blood glucose by stimulating peripheral glucose uptake by skeletal muscle and fat ...

US sales of Humalog in Q3 were nearly $415 million ... The FDA approved its short-acting insulin, Fiasp (insulin aspart injection) in September, and its long-acting insulin Tresiba (insulin ...

Despite being off-patent for many years, Humalog and other insulin brands continue to make high sales, with Lilly booking around $3 billion from its product last year, $1.8 billion of which was ...

Human insulin is a short-acting insulin used to treat type 1 and ... upper legs or upper arms. Never inject Humalog into a muscle or vein. Move to a new injection site every week or two.